Literature DB >> 30528710

Salivary markers of hepato-metabolic comorbidities in pediatric obesity.

Jacopo Troisi1, Federica Belmonte2, Antonella Bisogno2, Olga Lausi2, Francesca Marciano2, Pierpaolo Cavallo3, Salvatore Guercio Nuzio2, Annamaria Landolfi2, Luca Pierri2, Pietro Vajro4.   

Abstract

BACKGROUND: The pediatric obesity epidemic calls for the noninvasive detection of individuals at higher risk of complications. AIMS: To investigate the diagnostic role of combined salivary uric acid (UA), glucose and insulin levels to screen noninvasively for metabolic syndrome (MetS) and nonalcoholic fatty liver disease.
METHODS: Medical history, clinical, anthropometric, and laboratory data including serum triglyceride, glucose, insulin, HOMA, HDL-cholesterol, and UA levels of 23 obese children (15 with [St+] and 8 without [St-] ultrasonographic hepatic steatosis) and 18 normal weight controls were considered.
RESULTS: Serum and salivary UA (p < 0.05; R2 = 0.51), insulin (p < 0.0001; R2 = 0.79), and HOMA (p < 0.0001; R2 = 0.79) levels were significantly correlated; however their values tended to be only slightly higher in the obese patients, predominately in [St+], than in the controls. Notably, UA and insulin levels in both fluids increased in parallel to the number of MetS components. After conversion of the z-logit function including salivary/anthropometric parameters in a stepwise logistic regression analysis, a factor of 0.5 allowed for predicting hepatic steatosis with high sensitivity, specificity, and total accuracy.
CONCLUSIONS: Salivary testing together with selected anthropometric parameters helps to identify noninvasively obese children with hepatic steatosis and/or having MetS components.
Copyright © 2018 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Glucose; HOMA; Insulin; Metabolic syndrome; Saliva; Uric acid

Mesh:

Substances:

Year:  2018        PMID: 30528710     DOI: 10.1016/j.dld.2018.11.009

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN: 1590-8658            Impact factor:   4.088


  3 in total

1.  Metabolomic Salivary Signature of Pediatric Obesity Related Liver Disease and Metabolic Syndrome.

Authors:  Jacopo Troisi; Federica Belmonte; Antonella Bisogno; Luca Pierri; Angelo Colucci; Giovanni Scala; Pierpaolo Cavallo; Claudia Mandato; Antonella Di Nuzzi; Laura Di Michele; Anna Pia Delli Bovi; Salvatore Guercio Nuzio; Pietro Vajro
Journal:  Nutrients       Date:  2019-01-26       Impact factor: 5.717

2.  Pediatric non-alcoholic fatty liver disease: current perspectives on diagnosis and management.

Authors:  Anna Di Sessa; Grazia Cirillo; Stefano Guarino; Pierluigi Marzuillo; Emanuele Miraglia Del Giudice
Journal:  Pediatric Health Med Ther       Date:  2019-08-23

Review 3.  The Liver in Children With Metabolic Syndrome.

Authors:  Ebe D'Adamo; Valeria Castorani; Valerio Nobili
Journal:  Front Endocrinol (Lausanne)       Date:  2019-08-02       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.